STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
36 hedge funds and large institutions have $296M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 2 closing their positions.
Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
6
Increased
15
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
EAM
1
Eventide Asset Management
Boston,
Massachusetts
|
$20.6M |
2 |
GTC
2
Ghost Tree Capital
New York
|
$2.48M |
3 |
3
Janus Henderson Group
London,
United Kingdom
|
$1.38M |
4 |
4
BlackRock
New York
|
$4.6M |
5 |
5
State Street
Boston,
Massachusetts
|
$1.48M |